ReleaseWire Connect

Smart pills include medical devices and small embedded electronic appliances such as sensors, cameras and trackers. The innovative smart pill technology has reduced the gap between healthcare and digital technology.

Rising awareness concerning the effects of untreated sleep apnea in regions such as North America and the benefit of disability tax credit for sleep apnea in Canada are the factors that are likely to boost the market growth. A large count of diagnosed sleep apnea patients along with the higher healthcare costs associated with untreated sleep are the factors that foster the market growth.

Global Smart Transformer operates independently to regulate voltage, maintain contact with smart grid to permit remote access, and provide feedback in a power supply system. The remote access provided by smart transformers saves time and resources of users. An in-built monitoring function of smart transformers improves reliability by keeping a watch on critical components, such as winding, core, tap changer and others. Smart transformers protect electrical equipment from power fluctuations; reduce energy consumption and greenhouse emissions, and improve efficiency of electrical appliances. It is eco-friendly and enables users to save money by utilizing energy efficiently.

Generation of energy in any industry requires burning of fuels, of which coal and oil are a crucial part. Flue Gas consists of oxides of nitrogen & sulfur and particulate matter which causes air pollution and environmental degradation in the form of acid rain. According to an estimate, around 95% of sulfur is converted into sulfur dioxide under standard temperature conditions. Hence, there is a constant need for reducing sulfur emissions by regulating industrial emissions, which calls for different technologies for flue gas desulphurization.

Incretins are gut derived hormones, released after the ingestion of food. Incretins are classified into glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Both the molecules are inactivated by enzyme Dipeptidyl Peptidase-4 (DPP-4). Oral traditional anti-diabetic drugs, often fail to maintain the desired normal level of glucose, especially in the postprandial condition. This has resulted in a strong need for better therapeutics such as incretin based drugs. Incretin not only increases the secretion of insulin by acting on pancreatic beta cells, but also inhibits the release of glucagon by acting on the pancreatic alpha cells. Incretin based drugs namely; Incretin mimetics (GLP-1 agonist) and DPP-4 inhibitors work on the antidiabetic principle of incretin hormone. Incretin based drugs reduce body weight and have better cardiovascular outcomes. The major drivers of global incretin based drugs market are increasing incidence of diabetes, rising old age population, increasing rate of cardiovascular diseases and obesity, sedentary lifestyle and increasing awareness of diabetes. Furthermore, large number of either undiagnosed or pre-diabetic patients across the globe, could further fuel the market growth. However, high cost of treatment, lack of reimbursement, poor accessibility to drugs especially in developing countries, and some safety concerns associated with incretin based drugs, are likely to restrain the market.

Injectable drug delivery system is infusion method, which administers drug into body by piercing the skin with the help of syringe attached to the needle. Most popular route it follows includes intravenous (IV), subcutaneous (SC) or Intramuscular (IM) and exhibit cent percent bioavailability. It is promising alternative for drugs, which are poorly absorbed or ineffective, when administered orally. Injectable drug delivery market includes drug delivery devices and drug formulations that are expected to grow with a promising CAGR during the forecast period. Profound analysis of injectable drug delivery provides various aspects of market such as market trends, product analysis, market drivers, restrains and opportunities. Competitive landscape section focuses on key leaders within injectable drug delivery market and their major strategies to capture the market. In-depth segmental analysis helps to understand the market dynamics and also would be benefit professionals in the decision-making process.

Blood normally flows through arteries and veins in the circulatory system, but clot formation can block the flow of blood, which results in thrombosis. Clot formation in blood vessels is primarily the reason of various diseases that include heart attack, stroke, and venous thrombosis. Thus, antithrombotic drugs are used to reduce the formation of blood clots. These drugs can be categorized into two classes - anticoagulant and antiplatelet drugs. Anti-coagulant drugs reduce fibrin formation thereby slowing down the process of clotting, whereas antiplatelet drugs prevent clot formation by inhibiting platelet clumping.

Hematological disorders deal with blood related diseases and generally affect the quantity or functionality of the cells or proteins present in the blood. Some blood disorders result in the increase of the number of cells in blood such as anemia, leukopenia while other cause the number of blood cells to decrease such as leukocytosis and thrombocytosis. The modern approach of using point of care diagnostics, cytometry techniques in hematological disorder diagnosis have outpaced the traditional methods because they can be used even in the absence of healthcare personnel and in extreme conditions.

The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food. The scope of this report is to provide an insight on the various products available and to discuss the overall market scenario of animal antimicrobials.

According to a new report published by Allied Market Research, titled, Dental CAD/CAM Materials & Systems Market by Product: Global Opportunity Analysis and Industry Forecast, 2016-2023," the global dental CAD/CAM materials & systems market was valued at $1,675 million in 2016, and is projected to reach $3,161 million by 2023, growing at a CAGR of 9.4% from 2017 to 2023.